Repligen RGEN
NASDAQ RGEN
$164.68 -0.37 (-0.22%)
As of: Sep 10, 2026 · 3:59 PM EDT

Repligen (RGEN) Assets (QoQ) (2011 - 2026)

Analysis

Repligen (RGEN) Assets (QoQ) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.66%
Mar 31, 2026 -0.64%
Dec 31, 2025 0.89%
Sep 30, 2025 0.76%
Jun 30, 2025 1.73%
Mar 31, 2025 0.79%
Dec 31, 2024 -0.03%
Sep 30, 2024 -1.23%
Jun 30, 2024 0.43%
Mar 31, 2024 0.79%
Dec 31, 2023 12.23%
Sep 30, 2023 -1.34%
Jun 30, 2023 0.36%
Mar 31, 2023 0.65%
Dec 31, 2022 2.80%
Sep 30, 2022 0.72%
Jun 30, 2022 2.56%
Mar 31, 2022 1.08%
Dec 31, 2021 5.22%
Sep 30, 2021 11.18%